bpc-157 derived from gastric protective protein Frontiers Proposed targets for BPC 157

On notera une combinaison, en proportions variables d'un cas l'autre, des signes suivants [10] : troubles moteurs (dans 25 % des cas) consistant soit en un syndrome spastique (rigidit spastique des membres infrieurs, augmentation des rflexes tendineux, signe de Babinski positif), soit en un syndrome pseudo-tabtique (ataxie la marche, abolition des rflexes tendineux, signe de Romberg positif mais rflexes pupillaires normaux), troubles sensitifs avec paresthsies des doigts et des orteils dans 80 90 % des cas, troubles sphinctriens, prsents dans les cas les plus graves uniquement (incontinence urinaire) [11] , troubles psychiques (troubles du caractre, hallucinations)

The test level value was taken as two-sided 0.05 on both sides

The following table provides the outcome classification by treatment group on the Clinical Global Impression (CGI) improvement scale for Studies 1 and 2 combined: Exploratory analyses for age and gender effects on outcome did not suggest any differential responsiveness on the basis of age or sex

Collagen peptides help preserve skin structure and joint integrity, while investigational peptides such as BPC157 have accelerated wound healing and reduced inflammation in animal studies